STORM Therapeutics LTD
2 clinical trials · Sponsor
◉ Watch STORM Therapeutics LTD
| Record | Firm | Date |
|---|---|---|
| STC-15 as a Part of Combination Therapy With Toripalimab in Selected Advanced Cancers and as Monotherapy in Participants With Selected Sarcomas (NCT06975293) | STORM Therapeutics LTD | 2025-05-05 |
| Oral Administration of STC-15 in Subjects With Advanced Malignancies (NCT05584111) | STORM Therapeutics LTD | 2022-11-15 |
Track STORM Therapeutics LTD automatically
Every clearance here is in the API, with alerts when new ones post.